Trending Articles

article thumbnail

PBMs have evaded lawmakers’ reform attempts so far. Could 2025 turn the tide?

PharmaVoice

How regulators could hit PBMs from multiple sides in the coming year.

126
126
article thumbnail

Amgen’s lung cancer treatment gets conditional approval

PharmaTimes

IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer

Patients 106
article thumbnail

FDA Wraps Up 2024 Handing Out Several Notable Regulatory Decisions

MedCity News

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions. The post FDA Wraps Up 2024 Handing Out Several Notable Regulatory Decisions appeared first on MedCity News.

FDA 116
article thumbnail

Tirzepatide outpacing Wegovy in the obesity space

Pharmaceutical Technology

Eli Lilly and Novo Nordisk have been competing in the obesity market for the past year, making it an opportune time to review the benefits of the two most prominent obesity medications.

Medical 102
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Novo Nordisk asks FDA not to allow GLP-1 compounding

pharmaphorum

Novo Nordisk has asked the FDA to block compounders from making versions of its older, once-daily GLP-1 agonist liraglutide.

FDA 101
article thumbnail

4 companies to watch in the accelerating gene editing race

PharmaVoice

A handful of innovative startups are scrambling to gain a foothold as technology improves at a rapid clip.

126
126

More Trending

article thumbnail

EC approves Rybrevant with Lazcluze for advanced lung cancer

PharmaTimes

New chemotherapy-free treatment shows promise for EGFR-mutated NSCLC

101
101
article thumbnail

FDA issues first recommendations on AI for drug development

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has for the first time, issued draft guidance on using artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product. The guidelines address the safety, effectiveness or quality of these medicines. FDA has previously published a discussion paper that was produced to inform its guidance on AI in pharmaceutical drug development.

article thumbnail

Roche licenses Innovent ADC that could challenge Amgen drug

pharmaphorum

Roche licenses rights to a DLL3-targeted ADC from China's Innovent, hoping to bring a competitor to Amgen's lung cancer therapy Imdelltra to market

Marketing 101
article thumbnail

Goals of the Association for Prescription Psychedelics

Pharmaceutical Commerce

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), provides a peek into what the association has set out to accomplish.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Over 300 Organizations Call on New Congress to Safeguard and Strengthen Medicaid

MedCity News

Families USA led a letter urging the new Congress, which was sworn in on Jan. 3, to protect Medicaid. The post Over 300 Organizations Call on New Congress to Safeguard and Strengthen Medicaid appeared first on MedCity News.

99
article thumbnail

New prostate cancer test cuts biopsies by 50% in US

PharmaTimes

EpiSwitch PSE shows promise in reducing unnecessary procedures

92
article thumbnail

NICE makes first-of-a-kind recommendation for hearing loss drug

European Pharmaceutical Review

The National Institute for Health and Care Excellence (NICE) has recommended the first drug for NHS use to prevent cisplatin-induced hearing loss ( ototoxicity ) in children and young people between the ages of one month and 17 years old.Pedmarqsi (anhydrous sodium thiosulfate) is indicated for these children who have localised, non-metastatic, solid tumours.

article thumbnail

CARsgen gets a win for CAR-T in solid tumours

pharmaphorum

CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satri-cel has shown efficacy in gastric cancer, setting up a filing in China.

100
100
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA Publishes Final Guidance on Advanced Manufacturing Technologies

PharmaTech

The guidance provides recommendations for those interested in participating in FDAs Advanced Manufacturing Technologies Designation Program.

article thumbnail

5 Notable Health Tech Funding Announcements in December

MedCity News

Health tech companies made several major funding announcements in December. Here is a list of some of the biggest funding rounds. The post 5 Notable Health Tech Funding Announcements in December appeared first on MedCity News.

91
article thumbnail

UK regulator warns against buying weight-loss medicines without prescription

PharmaTimes

MHRA urges caution over illegal medicines from beauty salons and social media

article thumbnail

The year ahead for RNA therapeutic development and manufacturing

European Pharmaceutical Review

The RNA therapeutics industry stands poised for a transformative 2025, driven by breakthroughs in technology, expanding clinical applications, and a rapidly growing pipeline of innovative therapies. Following the unprecedented speed and success of mRNA-based COVID-19 vaccine development, the field has experienced a surge in investment and research to unlock the powerful potential of RNA for other therapeutic applications.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Capricor files cell therapy for DMD cardiomyopathy with FDA

pharmaphorum

Capricor completes its US filing for deramiocel, vying to become the first FDA-approved therapy for cardiomyopathy in Duchenne muscular dystrophy.

FDA 100
article thumbnail

FDA Releases Draft Guidance on Sampling and Testing of In-Process Materials and Drug Products

PharmaTech

The draft guidance document provides recommendations for complying with 21 CFR 211.110.

FDA 64
article thumbnail

Top Priorities and Challenges for Digital Health Leaders in 2025: 5 Key Insights

MedCity News

About 79% of digital health leaders said their companies are pursuing new investment capital in the next year, according to a recent survey from Summit Health Advisors. The post Top Priorities and Challenges for Digital Health Leaders in 2025: 5 Key Insights appeared first on MedCity News.

84
article thumbnail

FDA approves Sequana Medical’s Alfapump for ascites treatment

PharmaTimes

FDA gives green light to innovative device for liver conditions

FDA 86
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

IIT Guwahati and Bose Institute develop injectable hydrogel for cancer

Pharmaceutical Technology

The Indian Institute of Technology (IIT) Guwahati and the Bose Institute Kolkata research team have developed an advanced injectable hydrogel

64
article thumbnail

Early cancer diagnoses reach record level in NHS

pharmaphorum

Early cancer diagnoses have risen to record levels in England, says NHS, but long waiting times for treatment threaten to undermine the gains.

99
article thumbnail

How pharma was instrumental in President Jimmy Carter’s global health efforts

PharmaVoice

Pharma companies stepped up to support The Carter Center and provide access to life-saving treatments.

Pharma 64
article thumbnail

A Startup’s €90M Financing for Oral Peptide Drugs Includes Backing from Eli Lilly

MedCity News

Orbis Medicines Series A round of funding was led by New Enterprise Associates. The startup is developing oral macrocyclic drugs for targets validated by blockbuster biologic medications that must be administered by injection. The post A Startups 90M Financing for Oral Peptide Drugs Includes Backing from Eli Lilly appeared first on MedCity News.

article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

NHS Confederation welcomes social care commission announcement

PharmaTimes

Government announces independent commission on social care

article thumbnail

Astellas Pharma Recalls PROGRAF and ASTAGRAF XL Capsules

PharmaTech

The company is recalling one lot of PROGRAF 0.5mg (tacrolimus) and one lot of ASTAGRAF XL 0.5mg (tacrolimus extended-release) capsules because some bottles may contain empty capsules.

Pharma 64
article thumbnail

Hutchmed cashes in a Chinese JV to help fund its pipeline

pharmaphorum

Hutchmed has agreed to divest its share of a non-core Chinese JV through a pair of deals that will give it a cash injection to plough into R&D.

89
article thumbnail

Artificial intelligence and atopic dermatitis: A new era for disease management?

Pharmaceutical Technology

Effective management of atopic dermatitis (AD) has been one of the top priorities for physicians over the years, as quality of life in these patients is compromised due to the disruptive symptoms that they experience, which include itchiness and skin inflammation.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten